GlassScriptPhysician profile
Muzaffar Rahat
NPI 1336145762
$6,659.08
in general payments reported to CMS, 2019-2025
38 companies · $927 in 2025
The $927 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2020: $857 · 2021: $816 · 2022: $897 · 2023: $1,045 · 2024: $1,128 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,067.95 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,108.82 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $915.16 | 2019-2025 | Evenity, Repatha, Prolia |
| Astrazeneca Pharmaceuticals LP | $586.63 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $583.38 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $455.56 | 2021-2025 | |
| Pfizer INC. | $399.70 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $317.95 | 2019-2024 | Leqvio |
| Janssen Pharmaceuticals, INC | $270.01 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $251.71 | 2022-2025 | |
| Teva Pharmaceuticals USA, INC. | $221.26 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $199.22 | 2021-2025 | Gvoke Hypopen |
| Dexcom, INC. | $158.36 | 2021-2022 | |
| Abbott Laboratories | $135.66 | 2023-2024 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $132.44 | 2024 | Inspire |
| Astellas Pharma US INC | $115.60 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muzaffar Rahat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.